BAFNAPH

HealthcareDrug Manufacturers - Specialty & GenericMicro Cap
Bafna Pharmaceuticals Limited

Bafna Pharmaceuticals Limited (BAFNAPH) operates in the Healthcare sector as a Drug Manufacturer specializing in Specialty & Generic formulations. The company manufactures and sell...

हिन्दी में

Bafna Pharmaceuticals Limited (BAFNAPH) Healthcare सेक्टर में कार्यरत है, विशेष रूप से Specialty & Generic फॉर्मूलेशन के ड्रग मैन्युफैक्चरर के रूप में। कंपनी भारत में तैयार फार्मास...

₹418+1.99%1D
Previous trading day close · Data updates after market close
1W: +8.2%
1M: +38.6%
6M: +196.6%
1Y: +147.0%
51/100
Below AvgResearch Score
Market Cap
₹461 Cr
Micro Cap
P/E Ratio
46.13
Premium
P/B Ratio
6.04
Premium
ROE
5.0%
Weak
ROCE
14.5%
Good
Debt / Equity
0.33
Low debt
Div. Yield
N/A
EV/EBITDA
25.93
Expensive
52W Low: ₹94.77Current: ₹41852W High: ₹418
At 100% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
65/100
Growth
Revenue, EPS, profit growth
36/100
Valuation
PE, PB, EV/EBITDA vs sector
33/100
Risk
Debt levels, volatility, coverage
72/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
46.13(Premium)
Forward P/E
N/A
P/B Ratio
6.04(Premium)
P/S Ratio
3.30(Good)
EV/EBITDA
25.93(Expensive)
Dividend Yield
N/A
5Y CAGR
9.1%(Moderate)
Revenue Growth
4.6%(Moderate)
Profitability
ROE
5.0%(Average)
ROCE
14.5%(Good)
ROA
2.8%(Average)
Net Margin
7.1%(Low)
EBITDA Margin
13.3%
Financial Health
Debt to Equity
0.33(Low debt)
Current Ratio
1.63(Healthy)
Quick Ratio
1.09(Good)
Interest Coverage
4.00x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
100(Overbought)
RSI Exp (14)
100(Overbought)
MACD
31.285(Bullish)
MACD Signal
25.991
BB Position
94%(Upper band)
BB Width
43.17%(High volatility)
ADX (14)
73.5(Very Strong)
Williams %R
0.0(Overbought)
CCI (20)
138(Overbought)
Stoch %K
100(Overbought)
ATR (14)
7.20(Avg True Range)
OBV (M)
1.3(Positive)
1W OBV Chg
0.3%(Increasing)
Rel Volume
0.03x(Low activity)
Volatility
46.5%(High)
Max DD 1Y
-48.5%(High loss)
EMA 200
213.9
EMA 50
312.5
SMA 200
186.4
vs SMA 50
36.6%(Above SMA50)
vs SMA 200
124.2%(Above SMA200)
Volume
549
Avg Vol 3M
0.2L
Shareholding Pattern
Promoter
75.0%
High confidence
FII
9.3%
DII / MF
0.0%
Share BAFNAPH
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.